Joseph Miller

Joseph Miller

Directeur Financier/CFO chez LB PHARMACEUTICALS INC

Fortune : 10 M $ au 31/10/2026

52 ans
Health Technology
Commercial Services
Consumer Services

Profil

Mr. Joseph M.
Miller
, CPA, is a Chief Financial Officer at LB Pharmaceuticals, Inc. Mr. Miller was previously employed as a Chief Financial & Accounting Officer by Aurinia Pharmaceuticals, Inc., a Vice President-Finance by Sucampo Pharmaceuticals LLC, a Senior Director-Accounting by Qiagen Genomics, Inc., a Senior Director-Accounting by QIAGEN NV, a Chief Financial Officer & Vice President-Finance by Eppendorf Real Estate Corp., and a Chief Financial Officer & Vice President-Finance by Eppendorf-5 Prime, Inc. He also served on the board at Avalo Therapeutics, Inc. He received his undergraduate degree from Villanova University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
02/03/2026 576 421 ( 0,43 % ) 10 M $ 31/10/2026

Postes actifs de Joseph Miller

SociétésPosteDébut
LB PHARMACEUTICALS INC Directeur Financier/CFO 02/09/2026

Anciens postes connus de Joseph Miller

SociétésPosteFin
AURINIA PHARMACEUTICALS INC. Directeur Financier/CFO 20/03/2026
AVALO THERAPEUTICS, INC. Directeur Financier/CFO 24/04/2020
SUCAMPO PHARMACEUTICALS, INC. Directeur Financier/CFO 01/04/2018
Comptroller/Controller/Auditor 01/01/2015
QIAGEN N.V. Comptroller/Controller/Auditor 01/01/2015
Voir l'expérience en détail de Joseph Miller

Formation de Joseph Miller

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

63

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Eppendorf-5 Prime, Inc.

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Joseph Miller
🔇